Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes

ClinicalTrials.gov ID: NCT00002377

Public ClinicalTrials.gov record NCT00002377. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00002377
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • Valganciclovir Drug
  • Ganciclovir Drug

Drug

Eligibility (public fields only)

Age range
14 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 1996
Primary completion
Nov 30, 2002
Completion
Nov 30, 2002
Last update posted
May 16, 2017

1997 – 2002

United States locations

U.S. sites
15
U.S. states
8
U.S. cities
11
Facility City State ZIP Site status
Univ of California / Irvine Irvine California 92697
Univ of California / San Diego / Dept of Pediatrics La Jolla California 92093
Univ of California / San Diego Treatment Ctr San Diego California 92103
Davies Med Ctr / Institute for HIV Research San Francisco California 94114
Kaiser Permanente Med Ctr San Francisco California 94115
QUEST Clinical Research San Francisco California 94115
Dr Alan Palestine Washington D.C. District of Columbia 20006
Univ of Miami School of Medicine Miami Florida 33136
Emory Eye Clinic Atlanta Georgia 30322
New England Med Ctr Boston Massachusetts 02111
New York Univ Med Ctr New York New York 10016
St Luke's - Roosevelt Hosp Ctr / Div of Infect Dis New York New York 10019
New York Hosp - Cornell Med Ctr New York New York 10021
Duke Univ Eye Ctr Durham North Carolina 27710
Austin Infectious Disease Consultants Austin Texas 78705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002377, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 16, 2017 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002377 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →